Nancy Clare Heriza, MD in Baker City, OR - General Practice

Nancy Clare Heriza, MD is a General Practice physician based in Baker City, Oregon. Nancy Clare Heriza is licensed to practice in Oregon (license number M.D.14304) and her current practice location is 2339 Auburn Ave, Baker City, Oregon. She can be reached at her office (for appointments etc.) via phone at (541) 524-9490.

NPI number for Nancy Clare Heriza is 1487752515 and her current mailing address is 2339 Auburn Ave, Baker City, Oregon. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1487752515.

Contact Information

	Nancy Clare Heriza, MD
	2339 Auburn Ave, Baker City, OR 97814-3831
	(541) 524-9490
	(541) 524-9491

Physician's Profile

Full Name	Nancy Clare Heriza
Gender	Female
Speciality	General Practice
Location	2339 Auburn Ave, Baker City, Oregon
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1487752515
Provider Enumeration Date: 09/20/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Nancy Clare Heriza such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1487752515	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	M.D.14304 (Oregon)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Nancy Clare Heriza is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Nancy Clare Heriza, MD 2339 Auburn Ave, Baker City, OR 97814-3831 Ph: (541) 524-9490	Nancy Clare Heriza, MD 2339 Auburn Ave, Baker City, OR 97814-3831 Ph: (541) 524-9490

News Archive

Athera receives support from FP7 for development of fully human antibody PC-mAb

Athera Biotechnologies AB today announced that future development costs of its fully human antibody PC-mAb up until proof-of-concept will be co-funded by the European Union's Seventh Framework Programme for Research (FP7) through a collaborative research grant. Karolinska Development AB owns 65% of Athera Biotechnologies AB.

Physician earns Outstanding District Service Award from ACOG

Patrick Sweeney, MD, MPH, PhD, a long-time member of the medical staff at Women & Infants Hospital of Rhode Island and professor of obstetrics and gynecology at The Warren Alpert Medical School of Brown University, was recently presented with the Outstanding District Service Award by the American College of Obstetricians and Gynecologists (ACOG).

New York Times examines possible entry into global market of generic drugs for NCDs

The New York Times describes how, as the U.N. begins its meeting on non-communicable diseases (NCDs), Chinese and Indian generic drug makers "say they are on the verge of selling cheaper copies" of costly biotech medications used to treat cancers, diabetes, arthritis and other chronic illnesses.

New tool to assess excessive daytime sleepiness in adolescents

A study published in the October 15 issue of the Journal of Clinical Sleep Medicine (JCSM) features the Cleveland Adolescent Sleepiness Questionnaire (CASQ), a new self-completed instrument to measure excessive daytime sleepiness in adolescents.

Nancy Clare Heriza, MD - General Practice in Baker City, OR